IP Verse

Perfusion Bioreactor And Related Methods Of Use - EP3697887

PATENT ANALYSIS

Patent Details

Grant Date
Apr 6, 2022
Company
REGENERON PHARMACEUTICALS, INC.
Oppositions

SARTORIUS STEDIM BIOTECH GMBH

SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBB

More patents of Regeneron Pharmaceuticals, Inc.

EP4011915

EP2967015

EP3384049

Want to monitor this patent?

Feel free to send us a message here and we will get back to you